And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

Kenneth Greathouse Biography and Net Worth

Director of Zosano Pharma

Kenneth R. Greathouse has served as a member of our Board of Directors since September 2017. Mr. Greathouse is a seasoned pharmaceutical executive with over 40 years of experience in sales, marketing, business development and commercial operations. He is the co-founder of several successful drug development companies, including Manchester Pharmaceuticals which was sold to Retrophin Inc. in 2014. He began his career with Lederle Laboratories where for over 18 years he held a number of sales and marketing positions of increasing responsibility. He joined Athena Neurosciences in 1993 and continued with Elan Pharmaceuticals after the acquisition of Athena. After a two-year tenure at Boron LePore and Associates as Vice President and General Manager of Contract Sales, he joined Questcor as Senior Vice President, Commercial Operations. Since leaving Questcor, Mr. Greathouse has co-founded and served as CEO of Argent Development Group LLC, Melbourne Laboratories LLC, Valcrest Pharmaceuticals LLC, and Hesperian BioPharma LLC, in addition to Manchester Pharmaceuticals LLC.

What is Kenneth Greathouse's net worth?: The estimated net worth of Kenneth Greathouse is at least $40.00 as of December 6th, 2017. Mr. Greathouse owns 200,000 shares of Zosano Pharma stock worth more than $40 as of May 7th. This net worth approximation does not reflect any other assets that Mr. Greathouse may own. Learn More about Kenneth Greathouse's net worth.
How do I contact Kenneth Greathouse?: The corporate mailing address for Mr. Greathouse and other Zosano Pharma executives is 34790 ARDENTECH COURT, FREMONT CA, 94555. Zosano Pharma can also be reached via phone at (510) 745-1200 and via email at [email protected]. Learn More on Kenneth Greathouse's contact information.
Has Kenneth Greathouse been buying or selling shares of Zosano Pharma?: Kenneth Greathouse has not been actively trading shares of Zosano Pharma over the course of the past ninety days. Most recently, Kenneth Greathouse sold 10,000 shares of the business's stock in a transaction on Tuesday, November 23rd. The shares were sold at an average price of $0.60, for a transaction totalling $6,000.00. Learn More on Kenneth Greathouse's trading history.
Who are Zosano Pharma's active insiders?: Zosano Pharma's insider roster includes Kenneth Greathouse (Director), Hayley Lewis (Insider), and Steven Lo (CEO). Learn More on Zosano Pharma's active insiders.

Kenneth Greathouse Insider Trading History at Zosano Pharma

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/23/2021	Sell	10,000	$0.60	$6,000.00
12/6/2017	Buy	55,000	$0.61	$33,550.00	200,000
12/1/2017	Buy	95,000	$0.62	$58,900.00	95,000
11/15/2017	Buy	50,000	$0.62	$31,000.00	35,000

Kenneth Greathouse Buying and Selling Activity at Zosano Pharma

Zosano Pharma Company Overview

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

Today's Range

Now: $0.00

$0.00

50 Day Range

MA: $3.90

$0.52

$112.00

2 Week Range

Now: $0.00

$0.46

$37.45

Volume

5,685 shs

Average Volume

425,375 shs

Market Capitalization

$980.40

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.3

He Is Giving Away Bitcoin

From Crypto Swap Profits | Ad

>> Register right here